Singapore, Aug. 13 -- China-basedKexing Biopharmhas entered into a comprehensive strategic partnership with IQVIA, a global leader in clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries.

The partnership aims to accelerate the global clinical development, regulatory approval, and commercialisation of Kexing's innovative drugs and biosimilars, with a strategic focus on Europe and other regulated international markets.

In recent years, Kexing Biopharm has taken significant steps toward internationalization by building a unique globalization platform that integrates advanced R&D capabilities with agile commercial execution.

The company has successfully facilitated the o...